Search Results - "Frigeri, F."

THE ADDITION AT DAY 9 OF HD‐MTX TO THE (DA)‐EPOCH SCHEME WITH OR WITHOUT RITUXIMAB IS AN EFFECTIVE REGIMEN IN UNTREATED ADVANCED STAGE HIGH RISK LYMPHOMA: A FEASIBILITY STUDY by Farina, G., Iaccarino, S., Troiano, M., Iovine, M., Vigliotti, M., Attingenti, E., Camera, A., Frigeri, F.

Get full text

An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapy by Brancaccio, G, Sorbo, M.C, Frigeri, F, Rizzo, V, Cantone, M, Genderini, F, Fabeni, L, Pinto, A, Perno, C.F, Ceccherini-Silberstein, F, Gaeta, G.B

Get full text

Generation of precise calibration curve for absolute quantification of DNA target by Real-Time PCR. A method for accurate molecular monitoring of t(14;18)-bearing cells in Follicular Lymphoma by R. Di Francia, R. De Filippi, S. Crisci, G. Iaccarino, O. Catapano, E. Varriale, F. Frigeri, A. Pinto

“…Objective: Determination of absolute DNA concentration by Real-Time PCR is mandatory for an accurate molecular diagnosis. The critical step is a precise and…”
Get full text

PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3‐YEAR FOLLOW‐UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS by Bruzzese, A., Derudas, D., Galli, M., Martino, E. A., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangicavalli, S., Farina, G., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., Marcacci, G., Pietrantuono, G., Palumbo, G., Cascavilla, N., Cerchione, C., Belotti, A., Criscuolo, C., Uccello, G., Curci, P., Vigna, E., Mendicino, F., Iaccino, E., Mimmi, S., Botta, C., Vincelli, D., Sgherza, N., Bonalumi, A., Cupelli, L., Stocchi, R., Martino, M., Ballanti, S., Gangemi, D., Gagliardi, A., Gamberi, B., Pompa, A., Tripepi, G., Frigeri, F., Consoli, U., Bringhen, S., Zamagni, E., Patriarca, F., De Stefano, V., Di Raimondo, F., Palmieri, S., Petrucci, M. T., Offidani, M., Musto, P., Boccadoro, M., Cavo, M., Neri, A., Morabito, F., Gentile, M.

Get full text

DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents? by Marcacci, G, Corazzelli, G, Becchimanzi, C, Arcamone, M, Capobianco, G, Russo, F, Frigeri, F, Pinto, A

Get full text

Feasibility of bremsstrahlung dosimetry for direct dose estimation in patients undergoing treatment with 90Y-ibritumomab tiuxetan by Arrichiello, C., Aloj, L., Mormile, M., D’Ambrosio, L., Frigeri, F., Caracò, C., Arcamone, M., De Martinis, F., Pinto, A., Lastoria, S.

“…Purpose Radioimmunotherapy with 90 Y-ibritumomab tiuxetan has been used successfully used in the treatment of CD20-positive non-Hodgkin’s lymphoma (NHL)…”
Get full text

Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab by Rabascio, C, Laszlo, D, Andreola, G, Saronni, L, Radice, D, Rigacci, L, Fabbri, A, Frigeri, F, Calabrese, L, Billio, A, Bertolini, F, Martinelli, G

“…Abstract Purpose Resistance to nucleoside analogues agents is likely to be multifactorial and could involve a number of mechanisms affecting drug penetration,…”
Get full text

9249 Single vs double dose palonosetron for the prevention of acute and delayed nausea and vomiting in patients undergoing high dose chemotherapy and autologous stem cell transplantation by Marcacci, G, Becchimanzi, C, Arcamone, M, Capobianco, G, Corazzelli, G, Frigeri, F, Russo, F, Pinto, A

Get full text

Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine by Castrucci, G, Ferrari, M, Marchini, C, Salvatori, D, Provinciali, M, Tosini, A, Petrini, S, Sardonini, Q, Lo Dico, M, Frigeri, F, Amici, A

“…A bovine herpesvirus-1 (BHV-1) vaccine expressing glycoprotein D, the form with the transmembrane anchor removed, was evaluated for inducing immunity in…”
Get full text

Vaccination trials against bovine herpesvirus-1 by Castrucci, G, Ferrari, M, Salvatori, D, Sardonini, S, Frigeri, F, Petrini, S, Lo Dico, M, Marchini, C, Rotola, A, Amici, A, Provinciali, M, Tosini, A, Angelini, R, Cassai, E

Get full text

Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines by Castrucci, G, Frigeri, F, Salvatori, D, Ferrari, M, Sardonini, Q, Cassai, E, Lo Dico, M, Rotola, A, Angelini, R

“…Eight separate, but related experiments, were carried out in which groups of six calves were vaccinated with one of eight commercial vaccines. In each…”
Get full text

The use of immunomodulators in the control of infectious bovine rhinotracheitis by Castrucci, G, Osburn, B.I, Frigeri, F, Ferrari, M, Salvatori, D, Lo Dico, M, Barreca, F

“…Three experiments have been carried out to verify the effectiveness of an immunomodulator, Baypamun (Bayer AG) in limiting the spread of Bovine herpesvirus-1…”
Get full text

A study on latency in calves by five vaccines against bovine herpesvirus-1 infection by Castrucci, G, Frigeri, F, Salvatori, D, Ferrari, M, Lo Dico, M, Rotola, A, Sardonini, Q, Petrini, S, Cassai, E

“…Four bovine herpesvirus-1 (BHV-1) commercial vaccines, three of which (vaccines B, D, E) were modified live vaccines (MLV) and one (vaccine A) identified as a…”
Get full text

FRI-210 - An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapy by Brancaccio, G., Sorbo, M.C., Frigeri, F., Rizzo, V., Cantone, M., Genderini, F., Fabeni, L., Pinto, A., Perno, C.F., Ceccherini-Silberstein, F., Gaeta, G.B.

Get full text

JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis by Di Noto, R, Luciano, L, Lo Pardo, C, Ferrara, F, Frigeri, F, Mercuro, O, Lombardi, M L, Pane, F, Vacca, C, Manzo, C, Salvatore, F, Rotoli, B, Del Vecchio, L

“…Two novel cell lines (JURL-MK1 and JURL-MK2) have been established from the peripheral blood of a patient in the blastic phase of chronic myelogenous leukemia…”
Get full text

Chronic lymphocytic leukaemia and neuroendocrine cancer by Russo, F., Guadagni, S., Corazzelli, G., Frigeri, F., Monda, V. M., Abate, G.

“…We report a unique association between neuroendocrine cancer and chronic lymphocytic leukaemia (CLL) in a 63‐year‐old man. Neuroendocrine cancer was resistant…”
Get full text

PCV162 - Data Framework To Improve Relationship In Drugs Therapies Between Gps And Hospital Physicians by Voci, C, Cavana, M, Vecchi, E, Franchini, F, Borsari, M, Castanò, C, Frigeri, F

Get full text

Data Framework To Improve Relationship In Drugs Therapies Between Gps And Hospital Physicians by Voci, C, Cavana, M, Vecchi, E, Franchini, F, Borsari, M, Castanò, C, Frigeri, F

Get full text

Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia by Pane, F, Frigeri, F, Camera, A, Sindona, M, Brighel, F, Martinelli, V, Luciano, L, Selleri, C, Del Vecchio, L, Rotoli, B, Salvatore, F

Get more information

Single Vs Double Dose Palonosetron For The Prevention Of Acute And Delayed Nausea And Vomiting In Patients Undergoing High Dose Chemotherapy And Autologous Stem Cell Transplantation by Marcacci, G, Becchimanzi, C, Capobianco, G, Arcamone, M, Corazzelli, G, Frigeri, F, Russo, F, Pinto, A

Get full text